ESC 365 - Improved prognosis in hypertrophic cardiomyopathy over two decades - data from the Swedish national patient register

ESC2025 Premium Access

Improved prognosis in hypertrophic cardiomyopathy over two decades - data from the Swedish national patient register

Session: Precision medicine in hypertrophic cardiomyopathy

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor J. Silverdal (Gothenburg, SE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Jonas Silverdal

Sahlgrenska University Hospital, Gothenburg (Sweden)

0 follower

3 more presentations in this session

State-of-the-art lecture on precision medicine in hypertrophic cardiomyopathy

Speaker: Doctor C. Ho (Boston, US)

Integrated efficacy and safety analysis of mavacamten monotherapy in patients with obstructive hypertrophic cardiomyopathy

Speaker: Professor I. Olivotto (Florence, IT)

Cardiovascular magnetic resonance-derived metrics as diagnostic markers for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

Speaker: Mr G. Alexandridis (Rotterdam, NL)

Access the full session

Precision medicine in hypertrophic cardiomyopathy

Speakers: Doctor J. Silverdal, Doctor C. Ho, Professor I. Olivotto, Mr G. Alexandridis

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources